Heartbeam Inc./$BEAT
1D1W1MYTD1Y5YMAX
Capital at risk
About Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
- Ticker
- $BEAT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 16
- Headquarters
- Santa Clara, United States
- Website
- www.heartbeam.com
Heartbeam Inc. Metrics
BasicAdvanced
$24M
-
-$0.50
-0.79
-
Price and volume
Market cap
$24M
Beta
-0.79
52-week high
$4.00
52-week low
$0.39
Average daily volume
417K
Financial strength
Current ratio
3.657
Quick ratio
3.546
Profitability
EBITDA (TTM)
-20.303
Management effectiveness
Return on assets (TTM)
-153.52%
Return on equity (TTM)
-328.44%
Valuation
Price to book
2.89
Price to tangible book (TTM)
2.89
Price to free cash flow (TTM)
-1.227
Free cash flow yield (TTM)
-81.47%
Free cash flow per share (TTM)
-0.342
Growth
Earnings per share change (TTM)
-28.25%
3-year earnings per share growth (CAGR)
-27.80%
Upcoming events
No upcoming events
Heartbeam Inc. News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.